These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14273211)

  • 1. [TREATMENT OF GOUTY DYSPURINIA BY PARAMETABOLITES AND, ESPECIALLY, BY A XANTHINE OXIDASE INHIBITOR].
    DELBARRE F; AUSCHER C; LABROUSSE C; GERYA DE
    Presse Med (1893); 1965 May; 73():1275-9. PubMed ID: 14273211
    [No Abstract]   [Full Text] [Related]  

  • 2. THE RENAL EXCRETION OF OXYPURINES.
    GOLDFINGER S; KLINENBERG JR; SEEGMILLER JE
    J Clin Invest; 1965 Apr; 44(4):623-8. PubMed ID: 14278178
    [No Abstract]   [Full Text] [Related]  

  • 3. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS.
    HALL AP; HOLLOWAY VP; SCOTT JT
    Ann Rheum Dis; 1964 Nov; 23(6):439-46. PubMed ID: 14229577
    [No Abstract]   [Full Text] [Related]  

  • 4. NEW PROSPECTS IN THE TREATMENT OF GOUTY DYSPURINIA.
    DELBARRE F
    Arch Interam Rheumatol; 1964 Jun; 7():230-53. PubMed ID: 14209280
    [No Abstract]   [Full Text] [Related]  

  • 5. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT.
    KLINENBERG JR; GOLDFINGER SE; SEEGMILLER JE
    Ann Intern Med; 1965 Apr; 62():639-47. PubMed ID: 14274828
    [No Abstract]   [Full Text] [Related]  

  • 6. [DISEASES OF THE METABOLISM OF PURINES AND PYRIMIDINES].
    FRANCOMANERA R
    Rev Clin Esp; 1963 Aug; 90():203-16. PubMed ID: 14091043
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA; Krömer H; Scott JT; Watts RW
    Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
    [No Abstract]   [Full Text] [Related]  

  • 8. THE STUDY OF PURINE UTILIZATION AND EXCRETION IN A XANTHINURIC MAN.
    AYVAZIAN JH; SKUPP S
    J Clin Invest; 1965 Jul; 44(7):1248-60. PubMed ID: 14328401
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT.
    YUE TF; GUTMAN AB
    Am J Med; 1964 Dec; 37():885-98. PubMed ID: 14246090
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
    Delbarre F; Auscher C; de Gery A; Brouilhet H; Olivier JL
    Presse Med (1893); 1968 Dec; 76(49):2329. PubMed ID: 5737251
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible enzyme inhibitors. XCII. Inhibition of xanthine oxidase by some purines and pyrimidines.
    Baker BR; Hendrickson JL
    J Pharm Sci; 1967 Aug; 56(8):955-9. PubMed ID: 6035343
    [No Abstract]   [Full Text] [Related]  

  • 12. HEPATIC ALDEHYDE OXIDASE. 3. THE SUBSTRATE-BINDING SITE.
    RAJAGOPALAN KV; HANDLER P
    J Biol Chem; 1964 Jun; 239():2027-35. PubMed ID: 14213393
    [No Abstract]   [Full Text] [Related]  

  • 13. XANTHINE AS A PRECURSOR OF NUCLEIC ACID PURINES IN THE MOUSE.
    POMALES R; ELION GB; HITCHINGS GH
    Biochim Biophys Acta; 1965 Mar; 95():505-6. PubMed ID: 14342542
    [No Abstract]   [Full Text] [Related]  

  • 14. XANTHINE OXIDASE. VI. INFLUENCE OF PH ON SUBSTRATE SPECIFICITY.
    GREENLEE L; HANDLER P
    J Biol Chem; 1964 Apr; 239():1090-5. PubMed ID: 14165912
    [No Abstract]   [Full Text] [Related]  

  • 15. The separate determination of xanthine and hypoxanthine in urine and blood plasma by an enzymatic differential spectrophotometric method.
    Chalmers RA; Watts RW
    Analyst; 1969 Mar; 94(116):226-33. PubMed ID: 5775683
    [No Abstract]   [Full Text] [Related]  

  • 16. MULTIPLE BOVINE MYOGLOBIN INHIBITION OF CYTOCHROME C REDUCTION BY XANTHINE OXIDASE.
    QUINN JR; PEARSON AM
    Nature; 1964 Feb; 201():928-9. PubMed ID: 14132796
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypouricemic action of diflunisal in gouty patients: in vitro and in vivo studies.
    Ferraccioli G; Spisni A; Ambanelli U
    J Rheumatol; 1984 Jun; 11(3):330-2. PubMed ID: 6547486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible enzyme inhibitors. CXXVI. Hydrocarbon interaction with xanthine oxidase by phenyl substituents on purines and pyrazolo[3,4-d]pyrimidines.
    Baker BR; Wood WF; Kozma JA
    J Med Chem; 1968 Jul; 11(4):661-6. PubMed ID: 5671224
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
    Royer R; Vindel J; Lamarche M; Kissel P
    Presse Med (1893); 1968 Dec; 76(49):2325-7. PubMed ID: 5737250
    [No Abstract]   [Full Text] [Related]  

  • 20. Separate enzymatic determination of hypoxanthine and xanthine in human urine.
    Petersen BB; Jorni J; Jorgensen S
    Scand J Clin Lab Invest; 1965; 17(5):454-9. PubMed ID: 5839885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.